Malignant Solid Tumor
Showing 1 - 25 of >10,000
Advanced Solid Tumor Trial (SHR-4602 for injection)
Not yet recruiting
- Advanced Solid Tumor
- SHR-4602 for injection
- (no location specified)
Apr 6, 2023
HER2-positive Recurrent or Metastatic Malignant Solid Tumor Trial in Zhengzhou (Recombinant Humanized Bispecific Monoclonal
Recruiting
- HER2-positive Recurrent or Metastatic Malignant Solid Tumor
- Recombinant Humanized Bispecific Monoclonal Antibody MBS301
-
Zhengzhou, ChinaHenan Cancer Hospital
Nov 9, 2022
Advanced Solid Tumor Trial in Xuzhou (Oncolytic Virus Injection(Revottack)+PD-1)
Not yet recruiting
- Advanced Solid Tumor
- Oncolytic Virus Injection(Revottack)+PD-1
-
Xuzhou, Jiangsu, ChinaThe Affiliated Hospital of Xuzhou Medical University
Dec 1, 2022
Cutaneous Tumor, Malignant Solid Tumor Trial (JCXH-211 Injection)
Not yet recruiting
- Cutaneous Tumor
- Malignant Solid Tumor
- JCXH-211 Injection
- (no location specified)
Feb 13, 2023
Advanced Malignant Solid Tumors Trial in Shanghai (HMPL-415S1)
Not yet recruiting
- Advanced Malignant Solid Tumors
-
Shanghai, Shanghai, ChinaZhongshan Hospital Fudan University
May 23, 2023
Malignant Solid Tumor Trial (GEN1042, Pembrolizumab, Cisplatin)
Not yet recruiting
- Malignant Solid Tumor
- GEN1042
- +4 more
- (no location specified)
Sep 21, 2023
Malignant Solid Tumor Trial in Shanghai (Infusion of iNKT cells)
Completed
- Malignant Solid Tumor
- Infusion of iNKT cells
-
Shanghai, ChinaShanghai Public Health Clinical Center, Fudan University
May 6, 2022
Advanced Malignant Solid Tumor Trial in Huntersville (BNT314, Pembrolizumab)
Not yet recruiting
- Advanced Malignant Solid Tumor
- BNT314
- Pembrolizumab
-
Huntersville, North CarolinaCarolina BioOncology Institute, LLC
Nov 21, 2023
Cutaneous Tumor, Malignant Solid Tumor Trial in Houston (JCXH-211)
Not yet recruiting
- Cutaneous Tumor
- Malignant Solid Tumor
-
Houston, TexasThe University of Texas MD Anderson Cancer Center
Sep 9, 2022
Advanced Malignant Solid Tumor Trial in Hangzhou (9MW3811 Injection)
Not yet recruiting
- Advanced Malignant Solid Tumor
- 9MW3811 Injection
-
Hangzhou, Zhejiang, ChinaZhejiang Cancer Hospital
Jun 12, 2023
Non-squamous NSCLC, Epithelial Ovarian Cancer Trial (AMG 794)
Not yet recruiting
- Non-squamous Non-small Cell Lung Cancer
- Epithelial Ovarian Cancer
- AMG 794
-
Orange, CaliforniaUniversity of California at Irvine
Jan 25, 2023
Refractory Solid Tumor, Hepatocellular Carcinoma, Malignant Solid Tumor Trial in Memphis (Atezolizumab, Sorafenib, Bevacizumab)
Recruiting
- Refractory Solid Tumor
- +4 more
- Atezolizumab
- +3 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Aug 4, 2022
Malignant Solid Tumor Trial in Nashville (Ifetroban Sodium, Placebo)
Recruiting
- Malignant Solid Tumor
- Ifetroban Sodium
- Placebo
-
Nashville, TennesseeVanderbilt-Ingram Cancer Center
Jun 23, 2022
Advanced Malignant Solid Tumor Trial in Jinan, Shanghai (IAE0972)
Not yet recruiting
- Advanced Malignant Solid Tumor
-
Jinan, Shandong, China
- +1 more
May 24, 2022
Solid Tumor Trial in Beijing (JK-1201I)
Completed
- Solid Tumor
-
Beijing, Beijing, ChinaThe fifth medical center of PLA general hospital
Nov 16, 2021
Advanced Malignant Solid Tumor Trial in Hangzhou (Recombinant Human IL12/15 Dual-Regulated Oncolytic HSV-1 Injection)
Not yet recruiting
- Advanced Malignant Solid Tumor
- Recombinant Human IL12/15 Dual-Regulated Oncolytic HSV-1 Injection
-
Hangzhou, Zhejiang, ChinaThe First Affiliated Hospital,Zhejiang University School of Medi
Jul 25, 2022
Advanced Malignant Solid Tumors Trial in Nanchang (Neoantigen peptide vaccine, Neoantigen-based DC immune preparation)
Not yet recruiting
- Advanced Malignant Solid Tumors
- Neoantigen peptide vaccine
- Neoantigen-based DC immune preparation
-
Nanchang, Jiangxi, ChinaFirst Affiliated Hospital of Nanchang University
Mar 1, 2023
Advanced Solid Tumor, Stereotactic Body Radiotherapy, Immune Checkpoint Inhibitor Trial in Peking (Cadonilimab, Stereotactic
Not yet recruiting
- Advanced Solid Tumor
- +4 more
- Cadonilimab
- Stereotactic body radiotherapy
-
Peking, Beijing, ChinaDepartment of radiation oncology, Peking University Third Hospit
Jun 20, 2023
Carcinoma, Solid Tumor Trial in Suzhou (ADC Combined With Radiotherapy, PD-L1 Sequential GM-CSF and Thymopentin)
Not yet recruiting
- Carcinoma
- Solid Tumor
- ADC Combined With Radiotherapy, PD-L1 Sequential GM-CSF and Thymopentin
-
Suzhou, ChinaSecond Affiliated Hospital of Soochow University
Oct 26, 2023
Digestive System Malignant Solid Tumors Trial (ScTIL injection, ScTIL injection and B lymphocytes adjuvant)
Not yet recruiting
- Digestive System Malignant Solid Tumors
- ScTIL injection
- ScTIL injection and B lymphocytes adjuvant
- (no location specified)
Feb 7, 2023
Solid Tumor Trial (UCLM802 Cell Injection)
Not yet recruiting
- Solid Tumor
- UCLM802 Cell Injection
- (no location specified)
Mar 7, 2023
Tumor Infiltrating Lymphocytes, Safety, Advanced Solid Tumor Trial in Beijing (TIL therapy)
Recruiting
- Tumor Infiltrating Lymphocytes
- +5 more
- TIL therapy
-
Beijing, Beijing, ChinaChinese PLA General Hospital
Dec 19, 2022
Advanced Malignant Solid Tumor Trial in France, Netherlands (MP0317, a tri-specific fibroblast activation protein (FAP) x CD40
Recruiting
- Advanced Malignant Solid Tumor
- MP0317, a tri-specific fibroblast activation protein (FAP) x CD40 DARPin® drug candidate
-
Lyon, Cedex 08, France
- +3 more
Nov 4, 2022
Advanced Malignant Tumor Trial (HRS-2189 Tablets)
Not yet recruiting
- Advanced Malignant Tumor
- HRS-2189 Tablets
- (no location specified)
May 6, 2023